Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

New data shows that generic drivers are found in benign conditions

Prof Razelle Kurzrock - University of California, San Diego, USA
New data shows that generic drivers are found in benign conditions ( Prof Razelle Kurzrock - University of California, San Diego, USA )
30 Apr 2015

ecancermedicalscience editor's choice for April 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for April 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
30 Apr 2015

Positive results in phase II study of copanlisib treating NHL and CLL

Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Positive results in phase II study of copanlisib treating NHL and CLL ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
30 Apr 2015

Chk1 inhibition combined with standard dose gemcitabine may be safe and effective

Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Chk1 inhibition combined with standard dose gemcitabine may be safe and effective ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
29 Apr 2015

Latest trials and outcomes with new CLL treatments

Dr George Follows and Professor Peter Hillmen
Latest trials and outcomes with new CLL treatments ( Dr George Follows and Professor Peter Hillmen )
29 Apr 2015

The evolution of CLL treatment

Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence Cymbalista
The evolution of CLL treatment ( Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence Cymbalista )
28 Apr 2015

How to decide the treatment of CLL in 2015

Dr Marco Montillo and Dr Maria Gomes da Silva
How to decide the treatment of CLL in 2015 ( Dr Marco Montillo and Dr Maria Gomes da Silva )
24 Apr 2015

ecancermedicalscience editor's choice for February 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for February 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
3 Mar 2015

Effectiveness of adjuvant chemotherapy on patients with bladder cancer

Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
Effectiveness of adjuvant chemotherapy on patients with bladder cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )
2 Mar 2015

ASCO GU 2015 news roundup

Peter Goodwin - ecancer correspondent, London, UK
ASCO GU 2015 news roundup ( Peter Goodwin - ecancer correspondent, London, UK )
28 Feb 2015

Taxane response in prostate cancer may not be influenced by androgen receptor variations

Dr Emmanuel Antonarakis - Johns Hopkins School of Medicine, Baltimore, USA
Taxane response in prostate cancer may not be influenced by androgen receptor variations ( Dr Emmanuel Antonarakis - Johns Hopkins School of Medicine, Baltimore, USA )
28 Feb 2015

Combination of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma

Dr Martin Voss - Memorial Sloan Kettering Cancer Centre, New York City, USA
Combination of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma ( Dr Martin Voss - Memorial Sloan Kettering Cancer Centre, New York City, USA )
28 Feb 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation